BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Nomura maintains buy on Dr Reddy's Lab
Revises target price on the stock to Rs 4,919 from Rs 4,779. Dr Reddy's reported strong earnings in Q2 despite headwinds. Expect resolution of USFDA issues in next 12 months and do not factor in escalation to an import alert. Revise earnings estimates for FY16-18 by 2-3 per cent based on strong September numbers.